Status:
COMPLETED
Feasibility Trial Using an Inpatient Insulin Dosing Calculator
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main ...
Eligibility Criteria
Inclusion
- Patients who are admitted to University of Washington Medical Centers
- With history of type 2 and/or steroid-induced diabetes mellitus
- Receiving insulin therapy prior to admission
Exclusion
- Patients who are admitted to ICU or obstetrics ward
- Patients who are admitted for elective surgery or procedure
- Patients who present with diabetic ketone acidosis, hyperosmolar hyperglycemic state or require intravenous insulin infusion
- Patients who have no meal intake for 24 hours prior to admission, or planned nothing per oral (NPO) during the first 24 hours after admission
- Patients who report low appetite (25% or less) on admission or have a significantly decreased level of consciousness that they unlikely eat right after admission
- Patients who receive enteral feeding after admission
- Patients who develop severe acute kidney injury needing dialysis therapy
Key Trial Info
Start Date :
March 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06206525
Start Date
March 22 2024
End Date
May 31 2025
Last Update
July 15 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104
2
UW Medical Center - Northwest
Seattle, Washington, United States, 98133
3
UW Medical Center - Montlake
Seattle, Washington, United States, 98195